Proton-pump inhibitor use amongst patients with severe hypomagnesemia

Introduction: Long-term proton pump inhibitor (PPI) use has been associated with hypomagnesemia. It is unknown how frequently PPI use is implicated in patients with severe hypomagnesemia, and its clinical course or risk factors. Methods: All patients with severe hypomagnesemia from 2013 to 2016 in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Seah, Sherry, Tan, Yen Kheng, Teh, Kevin, Loh, Wann Jia, Tan, Pei Ting, Goh, Leng Chuan, Malakar, Roy Debajyoti, Aw, Tar Choon, Lau, Chin Shern, Dhalliwal, Trishpal, Kui, Swee Leng, Kam, Jia Wen, Khoo, Joan, Tay, Tunn Lin, Tan, Eberta, Au, Vanessa, Soh, Shui Boon, Zhang, Meifen, King, Thomas F., Gani, Linsey, Puar, Troy H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922884/
https://www.ncbi.nlm.nih.gov/pubmed/36794273
http://dx.doi.org/10.3389/fphar.2023.1092476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922884/
https://www.ncbi.nlm.nih.gov/pubmed/36794273
http://dx.doi.org/10.3389/fphar.2023.1092476

Ejemplares similares